Eastman Chemical Past Earnings Performance
Past criteria checks 4/6
Eastman Chemical has been growing earnings at an average annual rate of 2.7%, while the Chemicals industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 1.6% per year. Eastman Chemical's return on equity is 16.8%, and it has net margins of 10.2%.
Key information
2.7%
Earnings growth rate
6.6%
EPS growth rate
| Chemicals Industry Growth | 4.3% |
| Revenue growth rate | 1.6% |
| Return on equity | 16.8% |
| Net Margin | 10.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Eastman Chemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 9,108 | 925 | 766 | 236 |
| 31 Dec 23 | 9,210 | 894 | 768 | 239 |
| 30 Sep 23 | 9,376 | 585 | 694 | 246 |
| 30 Jun 23 | 9,818 | 708 | 679 | 254 |
| 31 Mar 23 | 10,278 | 692 | 648 | 261 |
| 31 Dec 22 | 10,580 | 793 | 625 | 264 |
| 30 Sep 22 | 10,901 | 1,170 | 364 | 267 |
| 30 Jun 22 | 10,912 | 1,220 | 386 | 265 |
| 31 Mar 22 | 10,781 | 818 | 400 | 261 |
| 31 Dec 21 | 10,476 | 857 | 383 | 254 |
| 30 Sep 21 | 9,968 | 511 | 861 | 244 |
| 30 Jun 21 | 9,370 | 321 | 831 | 234 |
| 31 Mar 21 | 8,641 | 494 | 791 | 223 |
| 31 Dec 20 | 8,473 | 478 | 773 | 226 |
| 30 Sep 20 | 8,492 | 472 | 688 | 229 |
| 30 Jun 20 | 8,695 | 577 | 696 | 232 |
| 31 Mar 20 | 9,134 | 808 | 715 | 237 |
| 31 Dec 19 | 9,273 | 759 | 751 | 234 |
| 30 Sep 19 | 9,444 | 767 | 689 | 233 |
| 30 Jun 19 | 9,666 | 913 | 690 | 234 |
| 31 Mar 19 | 9,924 | 999 | 702 | 237 |
| 31 Dec 18 | 10,151 | 1,080 | 693 | 235 |
| 30 Sep 18 | 10,137 | 1,537 | 597 | 229 |
| 30 Jun 18 | 10,055 | 1,448 | 605 | 228 |
| 31 Mar 18 | 9,853 | 1,396 | 600 | 226 |
| 31 Dec 17 | 9,549 | 1,384 | 594 | 227 |
| 30 Sep 17 | 9,375 | 1,009 | 619 | 230 |
| 30 Jun 17 | 9,197 | 918 | 648 | 225 |
| 31 Mar 17 | 9,075 | 881 | 671 | 222 |
| 31 Dec 16 | 9,008 | 854 | 695 | 223 |
| 30 Sep 16 | 9,045 | 862 | 734 | 237 |
| 30 Jun 16 | 9,205 | 886 | 734 | 238 |
| 31 Mar 16 | 9,441 | 928 | 745 | 240 |
| 31 Dec 15 | 9,648 | 848 | 743 | 242 |
| 30 Sep 15 | 9,772 | 740 | 710 | 223 |
| 30 Jun 15 | 9,738 | 694 | 688 | 224 |
| 31 Mar 15 | 9,665 | 687 | 665 | 223 |
| 31 Dec 14 | 9,527 | 749 | 709 | 227 |
| 30 Sep 14 | 9,443 | 1,079 | 679 | 220 |
| 30 Jun 14 | 9,368 | 1,177 | 670 | 212 |
| 31 Mar 14 | 9,348 | 1,151 | 680 | 207 |
| 31 Dec 13 | 9,350 | 1,165 | 685 | 203 |
| 30 Sep 13 | 9,254 | 765 | 645 | 200 |
| 30 Jun 13 | 9,175 | 611 | 646 | 204 |
Quality Earnings: 0IF3 has a large one-off gain of $297.0M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 0IF3's current net profit margins (10.2%) are higher than last year (6.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0IF3's earnings have grown by 2.7% per year over the past 5 years.
Accelerating Growth: 0IF3's earnings growth over the past year (33.7%) exceeds its 5-year average (2.7% per year).
Earnings vs Industry: 0IF3 earnings growth over the past year (33.7%) exceeded the Chemicals industry -18.4%.
Return on Equity
High ROE: 0IF3's Return on Equity (16.8%) is considered low.